These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 25275300)

  • 41. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functions of lncRNA HOTAIR in lung cancer.
    Loewen G; Jayawickramarajah J; Zhuo Y; Shan B
    J Hematol Oncol; 2014 Dec; 7():90. PubMed ID: 25491133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA HOTAIR Polymorphisms Association with Cancer Susceptibility in Different Tumor Types.
    Botti G; Collina F; Scognamiglio G; Aquino G; Cerrone M; Liguori G; Gigantino V; Malzone MG; Cantile M
    Curr Drug Targets; 2018; 19(10):1220-1226. PubMed ID: 28641521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNAs and neoplasia.
    Isin M; Dalay N
    Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress of long noncoding RNAs in anti-tumor resistance.
    Zhang H; Wang Y; Liu X; Li Y
    Pathol Res Pract; 2020 Nov; 216(11):153215. PubMed ID: 32979688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-coding RNAs, guardians of the p53 galaxy.
    Chen S; Thorne RF; Zhang XD; Wu M; Liu L
    Semin Cancer Biol; 2021 Oct; 75():72-83. PubMed ID: 32927018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells.
    Xiong XD; Ren X; Cai MY; Yang JW; Liu X; Yang JM
    Drug Resist Updat; 2016 May; 26():28-42. PubMed ID: 27180308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
    Abu N; Hon KW; Jeyaraman S; Jamal R
    Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNAs as novel therapeutic targets in cancer.
    Lavorgna G; Vago R; Sarmini M; Montorsi F; Salonia A; Bellone M
    Pharmacol Res; 2016 Aug; 110():131-138. PubMed ID: 27210721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding RNA HOTAIR in carcinogenesis and metastasis.
    Zhang J; Zhang P; Wang L; Piao HL; Ma L
    Acta Biochim Biophys Sin (Shanghai); 2014 Jan; 46(1):1-5. PubMed ID: 24165275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA HOTAIR in cervical cancer: Molecular marker, mechanistic insight, and therapeutic target.
    Zhou YH; Cui YH; Wang T; Luo Y
    Adv Clin Chem; 2020; 97():117-140. PubMed ID: 32448431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer.
    Zhou H; Feng B; Abudoureyimu M; Lai Y; Lin X; Tian C; Huang G; Chu X; Wang R
    Life Sci; 2020 Nov; 261():118362. PubMed ID: 32871184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastasis-associated long noncoding RNAs in gastrointestinal cancer: Implications for novel biomarkers and therapeutic targets.
    Zhang FF; Luo YH; Wang H; Zhao L
    World J Gastroenterol; 2016 Oct; 22(39):8735-8749. PubMed ID: 27818589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long Non-coding RNAs and Drug Resistance.
    Pan JJ; Xie XJ; Li X; Chen W
    Asian Pac J Cancer Prev; 2015; 16(18):8067-73. PubMed ID: 26745040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA as a multifunctional regulator in cancer multi-drug resistance.
    He J; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
    Mol Biol Rep; 2021 Aug; 48(8):1-15. PubMed ID: 34333735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TTN-AS1 as a potential diagnostic and prognostic biomarker for multiple cancers.
    Zheng QX; Wang J; Gu XY; Huang CH; Chen C; Hong M; Chen Z
    Biomed Pharmacother; 2021 Mar; 135():111169. PubMed ID: 33433359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.
    Zhang L; Xu X; Su X
    Mol Cancer; 2020 Mar; 19(1):48. PubMed ID: 32122338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
    Singh D; Khan MA; Siddique HR
    Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.